Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
You currently have
no recent searches
You currently have no recent searches
I had been scheduled to speak with Nancy Brinker tomorrow to discuss her new role as Chair of Komen’s Global Strategy and participation next week in Tanzania with President Barack Obama and former-President George W. Bush (who had appointed her as both Ambassador to Hungary and Chief of Protocol during his administration) in the African First Ladies Summit, “Investing in Women: Strengthening Africa.” But earlier today I was told that “events were changing on the ground there” and that the interview would have to be rescheduled for mid-July when she returned to the states.
I was also looking forward to discussing the selection of Judith Salerno, MD, MS, Chief Executive and COO of the National Academy of Sciences’ Institute of Medicine, as Komen’s new President and CEO, as well as the organization’s recent name change from Susan G. Komen for the Cure to simply Susan G. Komen. The organization had also been previously known as the Susan G. Komen Breast Cancer Foundation.
I hope to speak with both Brinker and Salerno for an update on these developments sometime soon.
Eric T. RosenthalEric T. Rosenthal has spent more than 40 years in journalism and academic public affairs, more than half of them involved in the cancer community. He has received several journalism awards as Special Correspondent for Oncology Times, and helped organize two national conferences dealing with medicine and the media.
Subscribe to this Blog's RSS Feed